$34.33
-0.16-0.46%
Last update: Sep 14, 10:14 AM
Indivior Pharmaceuticals Inc
INDVNASDAQ
Indivior Pharmaceuticals Earnings & Forecasts
Indivior Pharmaceuticals (INDV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Indivior Pharmaceuticals Guidance
Indivior Pharmaceuticals (INDV) last issued guidance on August 3, 2026 for fiscal year 2026. The company guided revenue in the range of $1.29B - $1.36B for the period.
Compared to prior guidance, Indivior Pharmaceuticals raised its revenue forecast from a prior range of $1.22B - $1.28B.
Indivior Pharmaceuticals has issued 17 guidance updates between October 23, 2023 and August 3, 2026. During this period, the company raised its outlook 5 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.92 | $0.66 | $0.66 | $0.40 |
| Actual | $1.15 | $0.96 | $0.82 | $0.72 |
| Surprise | +25.0% | +45.5% | +24.2% | +80.0% |
| Revenue | ||||
| Estimate | $306.8M | $272.0M | $305.5M | $261.1M |
| Actual | $343.0M | $317.0M | $358.0M | $314.0M |
| Surprise | +11.8% | +16.5% | +17.2% | +20.3% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $1.08 | $1.19 | $1.00 |
| Revenue | |||
| Consensus | $328.8M | $336.6M | — |
